South Africa Biomaterials in Healthcare Market Analysis Report 2022 to 2030

South Africa Biomaterials in Healthcare Market Analysis

$ 3999

South Africa Biomaterials in Healthcare Market is expected to grow from $1.01 Bn in 2022 to $2.98 Bn in 2030 with a CAGR of 14.43% for the forecasted year 2022-30. The lengthy life expectancy and increase in persistent health conditions in South Africa are increasing demand for medical implants, such as dental implants, spinal implants, and joint replacements. This demand is expected to lead to a rise in the demand for the biomaterials used in medical devices. The market is segmented by type and by application. Some key players in this market include Gabler Medical, Sinapi Biomedical, BASF SE, Johnson and Johnson, Medtronic, and Evonik Industries.

ID: IN10ZAMD003 CATEGORY: Medical Devices GEOGRAPHY: South Africa AUTHOR: Jigyasu Bhandari

Buy Now

South Africa Biomaterials in Healthcare Market Executive Analysis

South Africa Biomaterials in Healthcare Market is expected to grow from $1.01 Bn in 2022 to $2.98 Bn in 2030 with a CAGR of 14.43% for the forecasted year 2022-30. In comparison to other countries, South Africa invests more in healthcare (14% compared to 11%). The current government has been attempting to increase the size of the health spending line item. The high cost of implementing National Health Insurance (NHI), which is anticipated to reach $16.5 Bn yearly by 2025, will make it difficult. The South African health budget included $16.4 Bn, or 1.1% more than the prior year, for healthcare.

Biomaterials like titanium, cobalt-chromium, and polyethylene are commonly used to create orthopedic implants, such as hip and joint replacements. Dental implants are used to replace lost teeth and are constructed from biomaterials such as zirconia and titanium. Biomaterials like silicone and polyurethane are used to create mechanical heart valves, pacemakers, and other cardiovascular devices. In the treatment of wounds, biomaterials like collagen and hyaluronic acid are employed to promote tissue regeneration and recovery. Biomaterials don't harm viviparous organs because they are made to be biocompatible. As a consequence, there is less risk of infection and rejection. Biomaterials can be changed to accommodate particular patient and application needs. This enables improved outcomes and greater patient satisfaction. Because biomaterials are frequently more resilient than natural tissues, they can last longer and need fewer replacements. By encouraging tissue regeneration and healing, biomaterials can shorten recovery times and enhance patient outcomes.

south africa biomaterials in healthcare market

Market Dynamics

Market Growth Drivers

The lengthy life expectancy and increase in persistent health conditions in South Africa are increasing demand for medical implants, such as dental implants, spinal implants, and joint replacements. This demand is expected to lead to a rise in the demand for the biomaterials used in medical devices. As disposable money increases, people in South Africa are more willing to spend on healthcare services, including medical implants and devices. As a result, the industry is now friendlier to biomaterials manufacturers. As people in South Africa become more aware of the importance of health and wellbeing, they are more apt to seek medical interventions to improve their quality of life. Due to the increased demand for medical prosthetics and equipment, the country's biomaterials industry is expected to grow. As a result of advancements in material science and technology, new biomaterials have been developed that are more durable, biocompatible, and helpful in medical applications. Manufacturers now have the opportunity to develop and market novel biomaterials that will meet the needs of the South African healthcare industry.

Market Restraints

Conventional prostheses and devices, like metal and plastic ones, are well-established in the South African healthcare sector. Manufacturers of biomaterials must compete with these conventional devices in order to gain market dominance. Compared to more traditional medical devices and implants, biomaterials are costlier. This could be a major barrier for patients who are unable to pay for treatment, which could limit the market's growth. Lack of skilled healthcare workers who are adept at using biomaterials may be a major barrier to the market's growth. The adoption of biomaterials could be postponed as a result, which could limit overall demand for these products.

Competitive Landscape

Key Players

Gabler Medical (SA)
Sinapi biomedical (SA)
BASF SE
Johnson and Johnson
Medtronic
Evonik Industries

Healthcare Policies and Regulatory Landscape

In South Africa, biomaterials are governed by the South African Health Products Regulatory Authority (SAHPRA). The responsibility for assuring the high caliber, efficacy, and safety of medical devices falls to SAHPRA. A biomaterial needs to be licensed with SAHPRA before it can be marketed in South Africa. Information about the device, such as its intended use, manufacturing procedure, and clinical data, must be submitted as part of the registration process. South Africa's healthcare laws are governed by the National Health Act of 2003. The act lays out guidelines for the delivery of healthcare services and seeks to ensure that all South Africans have access to high-quality medical care.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the South Africa market in 2019. The growing geriatric population South Africaly is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.